Original Article

You have full text access to this OnlineOpen article

Prognostic stratification of patients with anaplastic gliomas according to genetic profile

  1. Caroline Dehais MD1,2,3,
  2. Florence Laigle-Donadey MD4,
  3. Yannick Marie MSc1,2,3,
  4. Michele Kujas MD5,
  5. Julie Lejeune PhD4,
  6. Alexandra Benouaich-Amiel MD1,2,3,4,
  7. Marta Pedretti MD1,2,3,
  8. Marc Polivka MD6,
  9. Khe-Hoang Xuan MD, PhD1,2,3,4,
  10. Joelle Thillet PhD1,2,3,
  11. Jean-Yves Delattre MD1,2,3,4,
  12. Marc Sanson MD, PhD1,2,3,4,†,*

Article first published online: 19 SEP 2006

DOI: 10.1002/cncr.22211

Issue

Cancer

Cancer

Volume 107, Issue 8, pages 1891–1897, 15 October 2006

Additional Information

How to Cite

Dehais, C., Laigle-Donadey, F., Marie, Y., Kujas, M., Lejeune, J., Benouaich-Amiel, A., Pedretti, M., Polivka, M., Xuan, K.-H., Thillet, J., Delattre, J.-Y. and Sanson, M. (2006), Prognostic stratification of patients with anaplastic gliomas according to genetic profile. Cancer, 107: 1891–1897. doi: 10.1002/cncr.22211

Author Information

  1. 1

    INSERM U711, Biologie des Interactions Neurones et Glie, Paris, France

  2. 2

    Universite Pierre et Marie Curie, Faculte de Medecine, Paris, France

  3. 3

    Groupe Hospitalier Pitie-Salpetriere, Paris, France

  4. 4

    Service de Neurologie Mazarin, Assistance Publique Hopitaux de Paris, Group Hospitalier, Salpetriere, Paris, France

  5. 5

    Laboratoire de Neuropathologie R. Escourolle, Assistance Publique Hopitaux de Paris, Group Hospitalier, Pitie-Salpetriere, Paris, France

  6. 6

    Service d'anatomopathologie, Hopital Lariboisiere, Paris, France

  1. †

    Fax: (011) 33 142160375

*Service de Neurologie Mazarin, Groupe Hospitalier Pitie-Salpetriere, 47 Boulevard de l'Hopital, 75013 Paris, France

Publication History

  1. Issue published online: 3 OCT 2006
  2. Article first published online: 19 SEP 2006
  3. Manuscript Accepted: 14 JUL 2006
  4. Manuscript Revised: 6 JUL 2006
  5. Manuscript Received: 25 MAY 2006

Funded by

  • Delegation a la Recherche Clinique. Grant Number: AP-HP Grant MUL 03012
  • Ligue Nationale Contre le Cancer, comite d'Ille et Vilaine

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (142K)

REFERENCES

  • 1
    Coons SW, Johnson P, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer. 1997; 79: 1381–1393.
    Direct Link:
  • 2
    Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998; 90: 1473–1479.
  • 3
    Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 2000; 18: 636–645.
  • 4
    Hoang-Xuan K, He J, Huguet S, et al. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology. 2001; 57: 1278–1281.
  • 5
    Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol. 2004; 22: 3133–3138.
  • 6
    Louis DN, Holland EC, Cairncross JG. Glioma classification: a molecular reappraisal. Am J Pathol. 2001; 159: 779–786.
  • 7
    He J, Mokhtari K, Sanson M, et al. Glioblastomas with an oligodendroglial component: a pathological and molecular study. J Neuropathol Exp Neurol. 2001; 60: 863–871.
  • 8
    Kujas M, Lejeune J, Amiel-Benouaich A, et al. Chromosome 1p loss: a favorable prognostic factor in low grade gliomas. Ann Neurol. 2005; 58: 322–326.
    Direct Link:
  • 9
    Berggren P, Kumar R, Sakano S, et al. Detecting homozygous deletions in the CDKN2A(P16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res. 2003; 9: 235–242.
  • 10
    Curran WJ, Scott CB, Horton J, et al. Recursive partitioning analysis of prognosis factors in the three Radiation Therapy Oncology Group malignant gliomas trials. J Natl Cancer Inst. 1993; 85: 704–710.
  • 11
    Mokhtari K, Paris S, Aguirre-Cruz L, et al. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol. 2005; 31: 62–69.
    Direct Link:
  • 12
    Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, et al. Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology. 2004; 63: 2360–2362.
  • 13
    Zlatescu MC, Tehrani-Yazdi A, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res. 2001; 61: 6713–6715.
  • 14
    Mueller W, Hartmann C, Hoffmann A, et al. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol. 2002; 161: 313–319.
  • 15
    van den Bent MJ, Carpentier A, Brandes AA, et al. Adjuvant PCV improves progression free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized EORTC Phase III trial. J Clin Oncol. 2006; 24: 2715–2722.
  • 16
    Idbaih A, Marie Y, Pierron G, et al. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol. 2005; 58: 483–487.
    Direct Link:
  • 17
    Houillier C, Lejeune J, Benouaich-Amiel A, et al. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer. 2006; 106: 2218–2223.
    Direct Link:
  • 18
    Stupp R, Mason W, van den Bent MJ, et al., European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups,National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352: 987–996.
  • 19
    Perry A, Aldape KD, George DH, Burger PC. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer. 2004; 101: 2318–2326.
    Direct Link:
View Full Article (HTML) Get PDF (142K)